Patients’ Preference Regarding Patient-Reported Outcome Measures for Hidradenitis Suppurativa: A Cross-Sectional Multicenter Study
Dermatology · 15.05.2026 · 1-8
DOI: 10.1159/000552227 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Dermatology, online erschienen am 15.05.2026. Verfasst von Johanna C van Huijstee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Erasmus University Medical Center, Rotterdam, The Netherlands, j.vanhuijstee@erasmusmc.nl. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa, Patient Reported Outcome Measures, Patient Preference. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Over the last decade, research interest in hidradenitis suppurativa (HS) has grown exponentially, resulting in a need for accurate outcome measures. However, subjective outcome measures included in research have not always been those that patients regard as most important or relevant. Therefore, this manuscript evaluates the preference of patients concerning three different patient-reported outcome measures (PROMs), the DLQI, HiSQOL, and Skindex-17.
Methods
This cross-sectional, multicenter study in the Netherlands included HS patients who completed the PROMs, each followed by the QQ-10 questionnaire. Their preference regarding these PROMs was evaluated using value and burden scores of the QQ-10 questionnaire, a ranking system, and open-end responses.
Results
A total of 200 patients were included in the study. The QQ-10 value scores for the DLQI, HiSQOL, and Skindex-17 were 66.3%, 67.1%, and 69.2%, respectively. The HiSQOL and Skindex-17 had a similar mean burden score of 23.8%, while the DLQI had a burden score of 24.4%. The Skindex-17 was ranked first by 41.5% of patients, followed by the HiSQOL (31.5%) and DLQI (27%). The Skindex-17 received the most negative feedback (85 comments), followed by the DLQI (84 comments), with both questionnaires receiving criticism primarily focused on their content. The HiSQOL received 57 comments, mainly concerning its design.
Conclusion
Patients did not demonstrate a clear preference among the three PROMs based on value and burden scores. However, qualitative feedback from open-ended responses suggests that the HiSQOL may be preferable, given its inclusion of HS-specific symptoms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Erasmus University Medical Center, Rotterdam, The Netherlands, j.vanhuijstee@erasmusmc.nl.
- Department of Dermatology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
- Department of Dermatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Zitieren
APA
van Huijstee, J. C., Koerts, N. D. K., Spence, C. C., Schappin, R., Horvath, B., & van der Zee, H. H. (2026). Patients’ Preference Regarding Patient-Reported Outcome Measures for Hidradenitis Suppurativa: A Cross-Sectional Multicenter Study. Dermatology, 1-8. https://doi.org/10.1159/000552227
Vancouver
van Huijstee JC, Koerts NDK, Spence CC, Schappin R, Horvath B, van der Zee HH. Patients’ Preference Regarding Patient-Reported Outcome Measures for Hidradenitis Suppurativa: A Cross-Sectional Multicenter Study. Dermatology. 2026:1-8. doi:10.1159/000552227
BibTeX
@article{vanHuijstee2026,
author = {van Huijstee, Johanna C and Koerts, Nicole D K and Spence, Colin C and Schappin, Renske and Horvath, Barbara and van der Zee, Hessel H},
title = {Patients’ Preference Regarding Patient-Reported Outcome Measures for Hidradenitis Suppurativa: A Cross-Sectional Multicenter Study},
journal = {Dermatology},
year = {2026},
pages = {1--8},
doi = {10.1159/000552227}
}
EUVIMED